Literature DB >> 647625

Monocyte function in patients with solid neoplasms during immunotherapy with Corynebacterium parvum.

M A Scheinberg, A Masuda, J A Maluf, N F Mendes.   

Abstract

The present studies were performed in order to evaluate monocyte function in patients with solid neoplasms before and after administration of C. parvum. The results demonstrate that monocytes from cancer patients display increased numbers of C3 and Fc receptor sites after administration of C. parvum. It is concluded that characterization of monocyte receptor activity may be helpful in monitoring the effects of immunotherapy in the immune system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647625     DOI: 10.1002/1097-0142(197805)41:5<1761::aid-cncr2820410517>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

2.  Augmentation of human blood monocyte microbicidal activity by RU 41740, a glycoprotein extract from Klebsiella pneumoniae.

Authors:  H Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Decreased monocyte antibody-dependent cell-mediated toxicity in stage I-II malignant melanoma. Augmentation by subcutaneous Corynebacterium parvum.

Authors:  J L Murray; E T Lee
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  The effect of piroxicam and auranofin on cell migration.

Authors:  H A Rueda; M A Scheinberg
Journal:  Clin Rheumatol       Date:  1985-03       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.